Insufficient evidence to recommend routine screening for cognitive decline. Changes to FDA approval process needed to improve safety

1. USPSTF finds insufficient evidence to recommend routine screening for cognitive declineThe United States Preventive Services Task Force (USPSTF) found insufficient evidence to recommend routine screening for cognitive decline in older adults in the primary care setting. Dementia affects up to 5.5 million Americans and its prevalence increases with age. Mild cognitive impairment (MCI) is a decline in cognitive function that is not severe enough to interfere with independence in daily life.